Session Details
[S8]Considering the Severity of Genetic Disorders in Preimplantation Genetic Testing
Thu. Nov 19, 2026 4:00 PM - 6:00 PM JST
Thu. Nov 19, 2026 7:00 AM - 9:00 AM UTC
Thu. Nov 19, 2026 7:00 AM - 9:00 AM UTC
Room 4 (Meeting Room 1, Exhibition Building, Sendai International Center)
Chair: Kiyonori Miura (Department of Obstetrics and Gynecology, Nagasaki University), Toshiyuki Yamamoto (Tokyo Women's Medical University)
[S8-1]Assessing Severity in Preimplantation Genetic Testing for Monogenic Disorders: Evolving Challenges in Japan
Aiko Sasaki (National Center for Child Health and Development)
[S8-2]Criteria for seriousness of hereditary disease is still in the process of being established
Koji Kugu (Department of Pharmaceutical Sciences, International University of Health and Welfare)
[S8-3]Reconsidering the severity of adult-onset hereditary neurological and neuromuscular disorders: A Neurologist's Perspective
Chisenn Takeuchi (Department of Clinical Genetics, Jikei University Hospital)
[S8-4]Considering Seriousness in Hereditary Tumors: Phenotypic Assessment and Genetic Counseling
Megumi Matsumoto1,2 (1. Division of Thoracic and Pelvic Surgery, Department of Surgery, Nagasaki University, 2. Genetic Counseling unit, Clinical Genomic Center, Nagasaki University Hospital)
[S8-5]Rethinking “Severity” in PGT-M: Five Questions on Perspective, Justification, and Responsibility
Momoko Sasaduki (Faculty of Human Sciences, Waseda University)
